UB
RCKT icon

UMB Bank’s Rocket Pharmaceuticals RCKT Stock Holding History

UMB Bank’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-572
Closed -$2.05K – 2354
2026
Q1 		$2.05K Sell
572
-1,474
-72% -$5.86K ﹤0.01% 2162
2025
Q4 		$7.18K Hold
2,046
– – ﹤0.01% 1931
2025
Q3 		$6.67K Buy
+2,046
New +$6.44K ﹤0.01% 1805
2024
Q4 		– Sell
-278
Closed -$5.13K – 2163
2024
Q3 		$5.13K Sell
278
-102
-27% -$2.09K ﹤0.01% 1720
2024
Q2 		$8.18K Sell
380
-28
-7% -$643 ﹤0.01% 1310
2024
Q1 		$11K Hold
408
– – ﹤0.01% 1259
2023
Q4 		$12.2K Buy
+408
New +$9.01K ﹤0.01% 1233

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UMB Bank's RCKT Position: Q2 2026 in Review

UMB Bank sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 572 shares — an estimated $2.05K sold.

UMB Bank first reported a position in RCKT in Q4 2023 and held it in 7 quarters. The position peaked at $12.2K in Q4 2023. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • UMB Bank reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • UMB Bank sold 572 Rocket Pharmaceuticals shares in Q2 2026, an estimated $2.05K.
  • UMB Bank first reported a position in Rocket Pharmaceuticals in Q4 2023 and held it in 7 quarters.
  • UMB Bank's Rocket Pharmaceuticals position peaked at $12.2K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.